ASX small caps are attracting heightened investor attention as severalCommodityand clean-energy themes converge in the market, driving strong interest acrossMiningand renewable-energy stories.
A snapshot of ASX micro-caps and small-caps making moves across biotech, gold, copper and clean-tech tells a similar story. Over the past week, fresh company updates have emerged from names including Amplia Therapeutics, Advance Metals, ClearVue Technologies, West Wits Mining and Neometals. Together, these …
Based on available market data, Cettire Ltd. shares may be rising on a combination of stock-specific positioning and broader sector sentiment. The move could reflect improving sentiment around Australian online retail as consumer activity stabilises. While there is no confirmed corporate news disclosed in …
ASX small-cap stocks remain firmly in focus as a wave of company-specific updates across mining, energy, technology and biotech shape investor interest. Recent coverage from Small Caps highlights a busy news cycle, with multiple companies releasing material updates that can move sentiment.
Koonenberry Gold Limited (ASX:KNB) delivered one of the more striking single-day performances among small-CapitalisationASX stocks on 19 May 2026, with shares rising 14.29% to AUD 0.024. The move came in direct response to an announcement that Managing Director Dan Power will step down from …
West Coast Silver Ltd (ASX:WCE) is reportedly accelerating work at its Elizabeth Hill silver project in the West Pilbara, with the junior explorer indicating it is moving toward what it describes as a fast-track development scenario. According to company updates summarised in industry coverage, …
ASX-listed Island Pharmaceuticals (ASX:ILA) stock in focus, after news of a deadly Ebola outbreak in the Democratic Republic of Congo prompted renewed investor interest in companies developing antiviral therapies. According to media reporting, the World Health Organisation has flagged the outbreak as a health …
Lumos Diagnostics (ASX:LDX) has reportedly been making progress on what investors had previously identified as the key catalysts for the stock: US regulatory clearance, reimbursement coverage and ongoing federally funded trial work. According to recent media coverage and company communications, the FebriDx point-of-care respiratory …
ASX defence stocks have reportedly been gaining attention as Canberra has flagged additional commitments under its National Defence Strategy and as AUKUS-related programs continue to scale up. Industry coverage has described the policy environment as one of the strongest tailwinds for the Australian defence …
Gold has remained one of the standout performers of 2026 so far, and according to recent commentary from market strategists, the bullish case is far from finished. Several largeInvestmentbanks have reportedly upgraded their gold price targets in recent months, with some now forecasting that …